Strategic alliance Oxford PharmaGenesis recently merged with Klick Health, creating a combined capability that spans scientific communications to commercialization, signaling a broad services footprint that can address end-to-end life sciences launches and evidence journeys.

Expanded scale Post-acquisition, the entity boasts over 500 advanced degree holders and more than 2100 experts, indicating greater capacity to support large pharma clients on complex oncology, rare disease, and specialty biologics programs.

Financial heft Reported revenue in the range of 250 to 500 million USD suggests substantial budget authority and investment capability for multi-year, multi-solution engagements with large life sciences brands.

Digital and AI readiness Recent integrations with AI and data platforms such as Elicit, plus a tech stack including SAS and digital collaboration tools, point to opportunities for advanced evidence synthesis, automation, and digital marketing optimization services.

Industry engagement Active participation in major healthcare communications forums, awards, and galas demonstrates strong industry footprint and relationship-building potential that can facilitate introductions to senior decision-makers and cross-functional teams.